Xia L, Yang C Q
Division of Gastroenterology and Hepatology, Tongji Hospital of Tongji University School of Medicine, Shanghai 200065, China.
Zhonghua Gan Zang Bing Za Zhi. 2017 Aug 20;25(8):566-570. doi: 10.3760/cma.j.issn.1007-3418.2017.08.003.
Hepatic fibrosis is a common pathological process in the development of various chronic liver diseases into liver cirrhosis. Based on current research findings, it is widely believed that the process of hepatic fibrosis is reversible, and effective treatment cannot only delay the development of hepatic fibrosis into liver cirrhosis, but also alleviate the degree of hepatic fibrosis. Therefore, the research on the treatment of hepatic fibrosis is of great clinical significance. The article reviews the recent research advances in the treatment of hepatic fibrosis.
肝纤维化是各种慢性肝病发展为肝硬化过程中的常见病理过程。基于目前的研究结果,人们普遍认为肝纤维化过程是可逆的,有效的治疗不仅可以延缓肝纤维化发展为肝硬化,还可以减轻肝纤维化程度。因此,肝纤维化治疗的研究具有重要的临床意义。本文综述了肝纤维化治疗的最新研究进展。